HireQuest (NASDAQ:HQI – Get Free Report) is anticipated to post its Q1 2025 quarterly earnings results after the market closes on Thursday, May 8th. Analysts expect HireQuest to post earnings of $0.14 per share and revenue of $8.03 million for the quarter.
HireQuest (NASDAQ:HQI – Get Free Report) last posted its quarterly earnings data on Thursday, March 27th. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.02. The firm had revenue of $8.08 million during the quarter, compared to analysts’ expectations of $9.30 million. HireQuest had a return on equity of 11.02% and a net margin of 4.04%. On average, analysts expect HireQuest to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.
HireQuest Price Performance
NASDAQ:HQI opened at $10.36 on Wednesday. The company has a market capitalization of $145.38 million, a price-to-earnings ratio of 94.18 and a beta of 1.20. The business has a 50 day moving average of $11.93 and a 200 day moving average of $13.28. HireQuest has a 1-year low of $9.98 and a 1-year high of $15.75.
HireQuest Dividend Announcement
Analysts Set New Price Targets
Separately, Barrington Research decreased their target price on shares of HireQuest from $18.00 to $16.00 and set an “outperform” rating on the stock in a research report on Monday, March 31st.
View Our Latest Stock Report on HireQuest
About HireQuest
HireQuest, Inc provides temporary staffing services in the United States. It offers staffing services, including direct-dispatch, executive search, consultant, unskilled and semi-skilled industrial and construction personnel, clerical and administrative personnel, and permanent placement services, as well as commercial and non-CDL drivers, and skilled personnel in the medical and dental industries.
See Also
- Five stocks we like better than HireQuest
- Trading Halts Explained
- 3 Mid-Cap Medical Stocks Outperforming the Market
- A Deeper Look at Bid-Ask Spreads
- The Top-Ranked Insider Buys From April by Market Cap
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for HireQuest Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HireQuest and related companies with MarketBeat.com's FREE daily email newsletter.